Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Net Margin (2020 - 2025)

Historic Net Margin for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 136.06%.

  • Strata Critical Medical's Net Margin rose 1258700.0% to 136.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.2%, marking a year-over-year increase of 357700.0%. This contributed to the annual value of 10.98% for FY2024, which is 139200.0% up from last year.
  • Latest data reveals that Strata Critical Medical reported Net Margin of 136.06% as of Q3 2025, which was up 1258700.0% from 5.29% recorded in Q2 2025.
  • Strata Critical Medical's Net Margin's 5-year high stood at 136.06% during Q3 2025, with a 5-year trough of 71.49% in Q4 2023.
  • Its 5-year average for Net Margin is 11.03%, with a median of 13.44% in 2024.
  • As far as peak fluctuations go, Strata Critical Medical's Net Margin plummeted by -598300bps in 2021, and later soared by 1258700bps in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Net Margin stood at 3.14% in 2021, then crashed by -1389bps to 40.42% in 2022, then plummeted by -77bps to 71.49% in 2023, then skyrocketed by 81bps to 13.44% in 2024, then surged by 1113bps to 136.06% in 2025.
  • Its Net Margin was 136.06% in Q3 2025, compared to 5.29% in Q2 2025 and 6.43% in Q1 2025.